Soleus Capital Master Fund, L.P. - 30 Jun 2025 SCHEDULE 13G/A Report for RIGEL PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (RIGL)

Filing Manager
Soleus Capital Master Fund, L.P.
Reporting Manager
Soleus Capital Master Fund, L.P.
Security
RIGEL PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share
Symbol
RIGL
Shares outstanding
17,787,703 shares
Disclosed Ownership
658,145 shares
Ownership
3.7%
Form type
SCHEDULE 13G/A
Filing time
05 Aug 2025, 17:00:03 UTC
Date of event
30 Jun 2025
Previous filing
11 Feb 2025
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Soleus Capital Master Fund, L.P. 3.7% 658,145 0 658,145 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital, LLC 3.7% 658,145 0 658,145 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Group, LLC 3.7% 658,145 0 658,145 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Management, L.P. 3.7% 658,145 0 658,145 /s/ Guy Levy Guy Levy/Managing Member
Soleus GP, LLC 3.7% 658,145 0 658,145 /s/ Guy Levy Guy Levy/Managing Member
Guy Levy 3.7% 658,145 0 658,145 /s/ Guy Levy Guy Levy